EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions

Sarah Hamidi, Mimi I Hu

Annales d'Endocrinologie · 2024-04 · 85 (2) · 118-126

DOI: 10.1016/j.ando.2024.02.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annales d'Endocrinologie, 2024-04. Verfasst von Sarah Hamidi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX, 77030, USA. Electronic address: sh…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Neuroendocrine, Multiple Endocrine Neoplasia Type 2a. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, NeuroendocrineMultiple Endocrine Neoplasia Type 2aHumansProto-Oncogene Proteins c-retMutationGerm-Line MutationProtein Kinase Inhibitors

Stichwörter der Autor:innen

Multikinase inhibitorNeoadjuvantRETRET inhibitorRET-altered thyroid cancerResistance mechanisms

Substanzen

Proto-Oncogene Proteins c-retProtein Kinase InhibitorsRET protein, human

Autor:innen und Institutionen

  • Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX, 77030, USA. Electronic address: shamidi@mdanderson.org.
  • Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, TX, 77030, USA.

Förderung

  • Eli Lilly and Company

Zitieren

APA

Hamidi, S., & Hu, M. I. (2024). RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions. Annales d'Endocrinologie, 85(2), 118-126. https://doi.org/10.1016/j.ando.2024.02.001

Vancouver

Hamidi S, Hu MI. RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions. Annales d'Endocrinologie. 2024;85(2):118-126. doi:10.1016/j.ando.2024.02.001

BibTeX
@article{Hamidi2024,
  author = {Hamidi, Sarah and Hu, Mimi I},
  title = {RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions},
  journal = {Annales d'Endocrinologie},
  year = {2024},
  volume = {85},
  number = {2},
  pages = {118--126},
  doi = {10.1016/j.ando.2024.02.001}
}
Kostenlos starten →